Skip to main content
Clinical Trials/CTRI/2024/09/074172
CTRI/2024/09/074172CompletedPhase 2

Evaluating the Efficacy of Twin Mixed Local Anaesthesia and Local Anaesthesia with Submucosal Dexamethasone Injection in Mandibular Third Molar Surgery – Prospective Comparative Clinical Trial

Karthiga M1 site in 1 country39 target enrollmentStarted: October 4, 2024Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
39
Locations
1
Primary Endpoint
POST OPERATIVE PAIN, FACIAL SWELLING AND MOUTH OPENING

Study Overview

Brief Summary

This is a prospective clinical trial with computer based randomisation to access pain during injection, onset and duration of analgesia, post operative pain, mouth opening and facial swelling. There is difference in pain during injection, onset of anaesthesia, duration of analgesia, reduction of postoperative pain, facial swelling followed by improvement in mouth opening.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
21.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Subjects above the age of 21 with mesioangular impacted mandibular third molar of Pell & Gregory Class-I, Level A.
  • •Subjects who are in good physical status.
  • •Subjects who could understand and are willing to take part in the study and likely to comply with all study procedures.

Exclusion Criteria

  • •Refusal to participate in the study.
  • •Pregnancy and lactation.
  • •Patient having systemic disorder like diabetes, hypertension, cardiac or neurological disorder.
  • •Patients with reduced mouth opening (mouth opening above 30mm was considered normal) Patient with history of drug allergy to lignocaine, dexamethasone, amoxicillin, metronidazole, diclofenac.
  • •Patients with active infection.
  • •Patient under any antibiotics or analgesics coverage.
  • •Patient other than Pell & Gregory Class-I Level A.
  • •Patients with severe oral manifestations of systemic disease.
  • •Psychologic or psychiatric conditions that could influence response to treatment.

Outcomes

Primary Outcomes

POST OPERATIVE PAIN, FACIAL SWELLING AND MOUTH OPENING

Time Frame: 7 days

Secondary Outcomes

  • INTRAOPERATIVE PAIN(3 HOURS)
  • POST OPERATIVE PAIN, FACIAL SWELLING AND MOUTH OPENING(3rd day, 7th day)

Investigators

Sponsor
Karthiga M
Sponsor Class
Other [pi]
Responsible Party
Principal Investigator
Principal Investigator

Karthiga M

Sri Balaji Vidyapeeth

Study Sites (1)

Loading locations...

Similar Trials